Hanx Biopharmaceuticals (Wuhan) Co., Ltd. ROE

The ROE as of October 2026 (TTM) for Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (3378.HK) is 13.13%

According to Hanx Biopharmaceuticals (Wuhan) Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is 13.13%. This represents a change of Infinity% compared to the average of 0% of the last 4 quarters.

Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (3378.HK) Historical ROE (quarterly & annually)

How has 3378.HK ROE performed in the past?

The mean historical ROE of Hanx Biopharmaceuticals (Wuhan) Co., Ltd. over the last ten years is 12.73%. The current 13.13% ROE has changed 3.11% with respect to the historical average. Over the past ten years (40 quarters), 3378.HK's ROE was at its highest in in the December 2016 quarter at 4.18%. The ROE was at its lowest in in the September 2010 quarter at 0%.

Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (3378.HK) ROE by Quarter and Year

Discovering the peaks and valleys of Hanx Biopharmaceuticals (Wuhan) Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (3378.HK) Average ROE

How has 3378.HK ROE performed in the past?

The current ROE of Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (3378.HK) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (3378.HK) ROE vs. Peers

How is 3378.HK’s ROE compared to its peers?

Hanx Biopharmaceuticals (Wuhan) Co., Ltd.’s ROE is greater than ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (-32.32%), greater than Alphamab Oncology (-10.27%), less than InnoCare Pharma Limited (12.35%), less than Antengene Corporation Limited (6.51%), greater than CStone Pharmaceuticals (-43.54%), greater than Akeso, Inc. (-10.86%), less than Lepu Biopharma Co., Ltd. (17.36%), greater than TYK Medicines, Inc (-77.60%), greater than 3D Medicines Inc. (-30.93%), greater than Ascentage Pharma Group International (-153.78%),

Build a custom stock screener for Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (3378.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hanx Biopharmaceuticals (Wuhan) Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (3378.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Hanx Biopharmaceuticals (Wuhan) Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.